Fidia Farmaceutici S.p.a.

Vincenza Corsa

Alessandro Negro

Giancarlo Carpanese

Susanna Vaccaro

Anna Maria Zanellato

Luciano Messina

Monica Campisi

Mara Pittarello

Francesco Borile

Sonia Bisicchia

The present invention concerns a process for the preparation and purification of the sodium salt of HA from the fermentation broth oforor from rooster combs, the sodium salt of HA obtained and purified with said process and pharmaceutical, cosmetic and nutritional compositions comprising said sodium salt of HA.

Process for the preparation and purification of the sodium salt of hyaluronic acid

A process is described for the purification of HA, and pharmaceutical, cosmetic and nutritional compositions containing HA thus purified.

Process for the purification of hyaluronic acid

The present invention relates to pharmaceutical formulations containing a combination of specific high-molecular weight hyaluronic acid derivatives and chondroitin sulfate to be used in the treatment of osteoarthritis, of subchondral damage, osteoporosis, synovitis, tenosynovitis, tendinitis, tendinosis, as an intra-articular washing liquid and as a viscous substitute of synovial fluid following osteochondral surgery. These formulations are also suitable for the treatment of interstitial cystitis.

Pharmaceutical formulations comprising chondroitin sulfate and hyaluronic acid derivatives

The present invention relates to a method for the production of hyaluronic acid (HA) inandthrough plasmid vectors wherein the gene is under the control of strong promoter P, and a system for the selection of stable bacterial strains for the production of high levels of hyaluronic acid.

[object Object]

A method of producing hyaluronic acid (HA) inandthrough episomal plasmid vectors wherein the gene is under the control of strong promoter T7, preferably under the control of strong promoter T7 of bacteriophage T7, and a system for the selection of stable bacterial strains producing high levels of hyaluronic acid, are provided.

The present invention relates to a method for the production of hyaluronic acid (HA) inandthrough plasmid vectors wherein the gene is under the control of strong promoter Pgrac, and a system for the selection of stable bacterial strains for the production of high levels of hyaluronic acid.

Growing community of inventors

Abano Terme, Italy

Vincenza Corsa